drugset / Trial / NCT02405793

Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain

NCT02405793

Phase 2 Withdrawn Iroko Pharmaceuticals, LLC
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of a low dose and a high dose of Meloxicam SoluMatrix® Capsules versus Meloxicam Tablets for the treatment of pain due to osteoarthritis of the knee or hip.

Timeline

Start
2015-05
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Meloxicam Small molecule

Indications